[go: up one dir, main page]

AU2003283508A1 - .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof - Google Patents

.pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof

Info

Publication number
AU2003283508A1
AU2003283508A1 AU2003283508A AU2003283508A AU2003283508A1 AU 2003283508 A1 AU2003283508 A1 AU 2003283508A1 AU 2003283508 A AU2003283508 A AU 2003283508A AU 2003283508 A AU2003283508 A AU 2003283508A AU 2003283508 A1 AU2003283508 A1 AU 2003283508A1
Authority
AU
Australia
Prior art keywords
thanspgreater
thansbgreater
thandless
than4less
spgreater
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003283508A
Other versions
AU2003283508A8 (en
Inventor
Joel Bockaert
Sylvie Claeysen
Aline Dumuis
Lara Joubert
Michele Sebben-Homburger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2003283508A8 publication Critical patent/AU2003283508A8/en
Publication of AU2003283508A1 publication Critical patent/AU2003283508A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003283508A 2002-10-10 2003-10-10 .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof Abandoned AU2003283508A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/12614 2002-10-10
FR0212614A FR2845604A1 (en) 2002-10-10 2002-10-10 Use of cDNA encoding a mutant 5-HT4 receptor for treatment or prevention of diseases associated with dysfunctional synthesis of cyclic adenosine monophosphate, e.g. neurodegeneration or asthma
PCT/FR2003/003002 WO2004033498A2 (en) 2002-10-10 2003-10-10 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
AU2003283508A8 AU2003283508A8 (en) 2004-05-04
AU2003283508A1 true AU2003283508A1 (en) 2004-05-04

Family

ID=32039620

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003283508A Abandoned AU2003283508A1 (en) 2002-10-10 2003-10-10 .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof

Country Status (3)

Country Link
AU (1) AU2003283508A1 (en)
FR (1) FR2845604A1 (en)
WO (1) WO2004033498A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004865A1 (en) * 2003-07-08 2005-01-20 Georg-August-Universität Göttingen Use of 5-ht4(a)-serotonin receptor agonists
WO2007048846A1 (en) * 2005-10-27 2007-05-03 Neuraxo Biopharmaceuticals Gmbh Use of iron-chelating compounds, cyclic adenosine monophosphate-increasing compounds or combinations thereof for treating axonal lesions in the cns

Also Published As

Publication number Publication date
FR2845604A1 (en) 2004-04-16
AU2003283508A8 (en) 2004-05-04
WO2004033498A3 (en) 2004-07-22
WO2004033498A2 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
EP1587474A3 (en) Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
AU2003291103A1 (en) Pharmaceutical composition
HUP0500610A3 (en) Indazoles, benzothiazoles, and benzoisothiazoles, pharmaceutical compositions comprises thereof and their uses
AU2003210001A1 (en) Medicament delivery device
AU2003299849A1 (en) Drug delivery apparatus
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
IL174479A (en) Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
AU2003250372A1 (en) Pharmaceutical composition
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
EP1831240B8 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003218359A1 (en) Polymer composition and dosage forms comprising the same
EP1556056A4 (en) X-nitro compounds, pharmaceutical compositions thereof and uses therof
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
AU2003284460A1 (en) Medicinal composition
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
AU2003291758A1 (en) Waxy matrix dosage forms
AU2003280799A1 (en) Medicinal composition
AU2003283508A1 (en) .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase